Clinical Trial Details

Short Title
LEPHT
Official Title

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction (LEPHT)

Description

The aim of this study is to assess whether increasing oral doses of Riociguat are safe and improve the well-being, symptoms and outcome in patients with pulmonary hypertension associated with left ventricular systolic dysfunction

This study is closed to enrollment and is in follow-up phase.

Please refer to www.clinicaltrials.gov identifier NCT01065454 for more information. 

Start Date
April 1, 2010
End Date
May 31, 2017
Gender Preference
None
Age Group
18 - 80 years
Principal Investigator
KellyAnn Light-McGroary, MD
Contact Info

Cardiomyopathy Treatment Program

Page Scovel, RN

phone:  319-356-1028

fax:  319-356-7087

email:  page-scovel@uiowa.edu

Department
Department or Field of Study
Keywords
cardiac disease ; Cardiomyopathy ; Congestive heart failure ; Heart ; Heart failure ; Left ventricular systolic dysfunction ; Pulmonary hypertension ; Pulmonary hypertension associated with left heart ;

We'd welcome your feedback!

Please help us improve your experience on our website by completing a brief survey

Yes, I'll give feedback No, Thanks

x